A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06425549 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06425549
- Sponsor
- UCB Biopharma SRL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-25
- Primary completion
- 2028-08-21
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.